Derrick Anderson
Family Medicine · Asheboro, NCNPI 1609876606
Payments from drug & device makers
Across 70 payments — averaging $32.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi US Services Inc.$965
- AbbVie$235
- GSK$143
- AstraZeneca$117
- Novo Nordisk$116
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$101
- plus $600 from 19 others
What the payments were for
- Food & beverage$1,312100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi US Services Inc. | 3 | $965 |
| AbbVie | 13 | $235 |
| GSK | 8 | $143 |
| AstraZeneca | 7 | $117 |
| Novo Nordisk | 7 | $116 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $101 |
| Johnson & Johnson | 1 | $95 |
| Bayer | 4 | $71 |
| Lilly USA, LLC | 4 | $64 |
| Amgen(2 entities) | 3 | $46 |
| Ironwood Pharmaceuticals, Inc | 2 | $45 |
| Exact Sciences | 2 | $41 |
| Boehringer Ingelheim | 2 | $36 |
| ANI Pharmaceuticals, Inc. | 2 | $28 |
| Neurocrine Biosciences, Inc. | 1 | $26 |
| Ionis Pharmaceuticals, Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
| Edwards Lifesciences | 1 | $15 |
| Redhill Biopharma Inc. | 1 | $14 |
| Gilead | 1 | $14 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $13 |
| Cranial Technologies, Inc | 1 | $13 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CAPLYTA$101
How this compares
$2,277 in reported general payments places this provider in the 80th percentile of 3,444 family medicine providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 47 | $44,745 |
| OzempicSemaglutide | 24 | $43,383 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 43 | $35,357 |
| JardianceEmpagliflozin | 37 | $33,661 |
| TradjentaLinagliptin | 38 | $29,101 |
| FarxigaDapagliflozin Propanediol | 12 | $19,648 |
| UbrelvyUbrogepant | 14 | $18,193 |
| JanuviaSitagliptin Phosphate | 19 | $11,180 |
| Tresiba Flextouch U-100Insulin Degludec | 18 | $9,599 |
| Emgality PenGalcanezumab-Gnlm | 12 | $8,143 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 13 | $5,980 |
| Spiriva HandihalerTiotropium Bromide | 12 | $5,779 |
| Humalog Kwikpen U-100Insulin Lispro | 21 | $4,360 |
| SymbicortBudesonide/Formoterol Fumarate | 17 | $4,160 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 35 | $3,981 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta, Stiolto Respimat | $36 | $68,74288 claims |
| Lilly USA, LLCTrulicity | $64 | $44,74547 claims |
| Novo NordiskOzempic | $116 | $43,38324 claims |
| GSKTrelegy Ellipta | $143 | $35,35743 claims |
| AstraZenecaFarxiga, Symbicort | $117 | $23,80829 claims |
| AbbVieUbrelvy | $235 | $18,19314 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,444 family medicine providers in North Carolina.
Other family medicine in Asheboro
- Barton WilliamsWilmington$17.3M
- Alexander MurrayGreensboro$13M
- Arin PiramzadianJacksonville$13M
- Jonathan WilsonHickory$12.7M
- George RaadCharlotte$7.7M
- Cecil FarringtonSalisbury$6.4M
- Christian MartinShelby$5.4M
- John EarlHickory$4.7M
- Patrick MorganteHavelock$4.6M
- Stephen JonesShelby$4.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.